- Home
- CTNM vs PAYS Comparison
CTNM vs PAYS Comparison
Compare CTNM & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- PAYS
- Stock Information
- Founded
- CTNM 2009
- PAYS 2001
- Country
- CTNM United States
- PAYS United States
- Employees
- CTNM N/A
- PAYS N/A
- Industry
- CTNM
- PAYS Business Services
- Sector
- CTNM
- PAYS Consumer Discretionary
- Exchange
- CTNM Nasdaq
- PAYS Nasdaq
- Market Cap
- CTNM 142.3M
- PAYS 125.2M
- IPO Year
- CTNM 2024
- PAYS 1998
- Fundamental
- Price
- CTNM $5.77
- PAYS $8.15
- Analyst Decision
- CTNM Strong Buy
- PAYS Strong Buy
- Analyst Count
- CTNM 4
- PAYS 4
- Target Price
- CTNM $22.50
- PAYS $7.06
- AVG Volume (30 Days)
- CTNM 366.4K
- PAYS 1.1M
- Earning Date
- CTNM 08-12-2025
- PAYS 08-05-2025
- Dividend Yield
- CTNM N/A
- PAYS N/A
- EPS Growth
- CTNM N/A
- PAYS N/A
- EPS
- CTNM N/A
- PAYS 0.11
- Revenue
- CTNM N/A
- PAYS $63,792,627.00
- Revenue This Year
- CTNM N/A
- PAYS $31.28
- Revenue Next Year
- CTNM N/A
- PAYS $19.36
- P/E Ratio
- CTNM N/A
- PAYS $74.39
- Revenue Growth
- CTNM N/A
- PAYS 26.77
- 52 Week Low
- CTNM $3.35
- PAYS $1.80
- 52 Week High
- CTNM $21.58
- PAYS $8.88
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- PAYS 64.92
- Support Level
- CTNM N/A
- PAYS $7.55
- Resistance Level
- CTNM N/A
- PAYS $8.88
- Average True Range (ATR)
- CTNM 0.00
- PAYS 0.51
- MACD
- CTNM 0.00
- PAYS -0.08
- Stochastic Oscillator
- CTNM 0.00
- PAYS 49.31
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.